SGEN Financial Facts

Income (loss) from operations: -32.41M
Revenue from collaboration and license agreements: 23.97M
See Full Income Statement

Accumulated deficit: -1.01B
Total liabilities and stockholders' equity: 849.91M
See Full Balance Sheet

Seattle Genetics Inc. (SGEN) Earnings

  |   Expand Research on SGEN
Next EPS Date 2/8/17 *Est. EPS Growth Rate -9.5% *Last Qtr.
Average EPS % Beat Rate -2.0% Revenue Growth Rate +26.4% *Last Qtr.
Average % Move 1-Wk after EPS +5.1% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/27/16 Q316 -$0.23-$0.29 +$0.06$106.3M$101.74M N/A Details
7/26/16 Q216 -$0.23-$0.32 +$0.09$95.4M$94.14M N/A Details
4/28/16 Q116 -$0.15-$0.09 -$0.06$111.2M$116.49M N/A Details
2/9/16 Q415 -$0.18-$0.20 +$0.02$93.5M$88.28M N/A Details
10/29/15 Q315 -$0.21-$0.20 -$0.01$84.1M$82.67M N/A Details
7/30/15 Q215 -$0.38-$0.26 -$0.12$77.1M$77.97M N/A Details
2/10/15 Q414 -$0.22-$0.25 +$0.03$74.3M$68.34M N/A Details
10/30/14 Q314 -$0.13-$0.24 +$0.11$75.8M$66.9M N/A Details